期刊文献+

机器人胸腺扩大切除术在重症肌无力患者中的应用价值 被引量:2

Application value of robotic-assisted extended thymectomy in patients with myasthenia gravis
下载PDF
导出
摘要 目的探讨应用达芬奇机器人行三孔式剑突下入路胸腺扩大切除术在重症肌无力外科治疗中的应用价值。方法纳入江西省人民医院胸外科于2021年6月至2023年3月期间使用达芬奇Xi手术机器人系统行胸腺扩大切除术的重症肌无力患者23例,所有患者使用机器人剑突下三孔法完成手术。统计手术时间、术中出血量、术后住院时间、术后2个月重症肌无力定量评分量表(QMGS)评分等指标并进行分析。结果所有患者顺利完成手术,无中转开胸、围术期死亡病例。手术时间130~370(228.46±81.02)min,术中出血量20~250(92.30±87.86)ml,术后入住胸外科重症监护病房(ICU)时间1~18(3.54±4.58)d,术后气管插管呼吸机辅助通气时间1~8(1.77±2.17)d,术后24 h胸腔引流量70~380(179.62±101.31)ml,术后胸管留置时间2~12(4.62±2.90)d,术后住院时间4~32(10.38±7.88)d,切除的肿物标本体积126.0~538.2(275.22±140.29)cm^(3),淋巴结清扫数目1~26(5.62±7.72)个,均为肿瘤学阴性淋巴结。术后2个月,QMGS评分(4.46±4.31)分,QMGS相对评分(0.59±0.24)分,胸部CT均未见明显异常。除1例术后发生肌无力危象外,无其他并发症发生。结论传统胸腔镜三孔式剑突下入路的手术技术改良后应用于达芬奇机器人行胸腺扩大切除术,可实现全胸腺切除、纵隔脂肪组织廓清,手术安全可靠,治疗重症肌无力疗效确切。 Objective To explore the application value of Da Vinci robot to perform the extended thymectomy for the treatment of myasthenia gravis through the three-port subxiphoid approach.Methods From June 2021 to March 2023,23 patients with myasthenia gravis who received Da Vinci Xi robot to perform the extended thymectomy for the treatment of myasthenia gravis through the three-port subxiphoid approach in the Department of Thoracic Surgery of Jiangxi Provincial People′s Hospital were included in this study.The indicators such as surgical time,intraoperative blood loss,postoperative hospitalization time,and the Quantitative Myasthenia Gravis Scale(QMGS)score 2 months after surgery were statistically analyzed.Results The operations of all the patients were successfully completed,and there was no conversion to thoracotomy and no perioperative death.The surgical time was 130-370(228.46±81.02)minutes.The intraoperative bleeding volume was 20-250(92.30±87.86)ml.The time of admission to the thoracic intensive care unit(ICU)after surgery was 1-18(3.54±4.58)days.The postoperative tracheal intubation ventilator assisted ventilation time was 1-8(1.77±2.17)days.The postoperative 24-hour thoracic drainage was 70-380(179.62±101.31)ml.The postoperative thoracic tube cannulation time was 2-12(4.62±2.90)days.The postoperative hospitalization time was 4-32(10.38±7.88)days.The volume of resected tumor specimens was 126.0-538.2(275.22±140.29)cm^(3) and the number of dissected lymph nodes was 1-26(5.62±7.72).All the dissected lymph nodes were oncology-negative.The QMGS scores were(4.46±4.31)points 2 months after surgery,and the relative scores of QMGS were(0.59±0.24)points 2 months after surgery.No significant abnormalities were found on the chest computed tomography(CT)2 months after surgery.No other complications occurred except for one case of postoperative myasthenic crisis.Conclusion The traditional thoracoscopic three-port subxiphoid approach has been modified and applied to Da Vinci robot for extended thymectomy,which can achieve complete thymectomy and clearance of mediastinal adipose tissues,making the operation safe and reliable,and the therapeutic effects of myasthenia gravis are definite.
作者 习锦峰 徐全 XI Jin-feng;XU Quan(Nanchang University Jiangxi Medical College,Jiangxi 330000,China;Department of Thoracic Surgery,Jiangxi Provincial People′s Hospital(the First Affiliated Hospital of Nanchang Medical College),Nanchang 330006,China)
出处 《中国临床新医学》 2023年第6期542-546,共5页 CHINESE JOURNAL OF NEW CLINICAL MEDICINE
关键词 达芬奇机器人 三孔式剑突下入路 胸腺扩大切除术 重症肌无力 Da Vinci robot Three-port subxiphoid approach Extended thymectomy Myasthenia gravis
  • 相关文献

参考文献4

二级参考文献31

  • 1刘会平,李剑锋,吴怡成,谢明儒,刘永恒,姜冠潮,刘军,王俊.电视胸腔镜胸腺扩大切除治疗重症肌无力107例临床分析[J].中华外科杂志,2005,43(10):625-627. 被引量:38
  • 2Masaoka A, Monden Y, Nakahara K, et al. Follow-up study of thymo-mas with special reference 10 their clinical stages. Cancer, 1981,48: 2485-2492.
  • 3Koga K, Matsuno Y, Noguchi M, e t aJ. A review of 79 thymomas: modification of staging system and reappraisal of conventional division into invasive and non-invasive thymoma. Pathol Int, 1994,44: 359-367.
  • 4HuangJ, Wang Z, Loehrer P, et al. Standard outcome measures for thymic malignancies.J Thorac Oncol, 2010, 5: 2017-2023.
  • 5Bergh N, Gatzinsky P, Larsson S, et al. Tumors of the thymus and thymic region. L Clinicopathological studies on thymomas. Ann Thorac Surg, 1978, 25: 91-98.
  • 6Wilkins EJ, Castleman B. Thymoma: a continuing survey at the Mas?sachusetts General Hospital. Ann Thorac Surg, 1979,28: 252-256.
  • 7VerleyJM, Hollmann KH. Thymoma: a comparative study of clinical stages, histologic features, and survival in 200 cases. Cancer, 1985, 55: 1074-1086.
  • 8Regnard J-F, Magdeleinat P, Dromer C, et al. Prognostic factors and long?term results after thymoma resection: a series of 307 patients. J Thorac Cardiovasc Surg, 1996, 112: 376-384.
  • 9WeydertJ, De Young B, Leslie K. Recommendations for the reporting of surgically resected thymic epithelial tumors. AmJ Clin Pathol , 2009, 132: 10-15.
  • 10Gamonde's JP, Balawi A, Greenland T, et al. Seventeen years of surgical treatment of thymoma: factors influencing survival. Eur J Cardio-Thorac Surg, 1991,5: 124-131.

共引文献20

同被引文献16

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部